💼 Business
4d ago
RFK Jr.'s peptide policy could boost Hims & Hers as its GLP-1 business evolves
Source ↗
👁 0
💬 0
Hims may have a chance to grow peptides business as a potential revenue driver, with FDA review in 2026 shaping the opportunity.
Comments (0)